These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 9861261)

  • 21. Clinical images: Divergent patterns of joint remodeling following effective urate-lowering therapy in tophaceous gout.
    Dalbeth N; Doyle A; McQueen FM
    Arthritis Rheum; 2011 Jan; 63(1):266. PubMed ID: 20722028
    [No Abstract]   [Full Text] [Related]  

  • 22. The current state of care in gout: Addressing the need for better understanding of an ancient disease.
    Zychowicz ME; Pope RS; Graser E
    J Am Acad Nurse Pract; 2010 Nov; 22 Suppl 1():623-36. PubMed ID: 21054636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with acute gout attacks in normouricaemic gout patients receiving allopurinol: a retrospective study.
    So MW; Lee SG; Kim YG; Lee CK; Yoo B
    Scand J Rheumatol; 2011 Nov; 40(6):444-7. PubMed ID: 21916803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risks and benefits of drugs used in the management and prevention of gout.
    Conaghan PG; Day RO
    Drug Saf; 1994 Oct; 11(4):252-8. PubMed ID: 7848545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational treatment of gout. Stopping an attack and preventing recurrence.
    Vawter RL; Antonelli MA
    Postgrad Med; 1992 Feb; 91(2):115-8, 127. PubMed ID: 1738733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hyperuricemia/gout. Main symptoms of arthropathy. Severe acute joint pain, redness, inflammation].
    Kolyvanos Naumann U; Suter PM; Käser L; Vetter W
    Praxis (Bern 1994); 2005 Apr; 94(14):543-8; quiz 549. PubMed ID: 15849976
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical features of gout in a cohort of Italian patients].
    Zampogna G; Andracco R; Parodi M; Cimmino MA
    Reumatismo; 2009; 61(1):41-7. PubMed ID: 19370187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Withdrawal of longterm antihyperuricemic therapy in tophaceous gout.
    van Lieshout-Zuidema MF; Breedveld FC
    J Rheumatol; 1993 Aug; 20(8):1383-5. PubMed ID: 8230024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts.
    Perez-Ruiz F; Calabozo M; Herrero-Beites AM; García-Erauskin G; Pijoan JI
    Nephron; 2000 Nov; 86(3):287-91. PubMed ID: 11096285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gout: modern management of an ancient malady.
    Boyd RE
    J S C Med Assoc; 1993 May; 89(5):240-3. PubMed ID: 8515662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of gout: a 57-year-old man with a history of podagra, hyperuricemia, and mild renal insufficiency.
    Shmerling RH
    JAMA; 2012 Nov; 308(20):2133-41. PubMed ID: 23188030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical practice. Gout.
    Terkeltaub RA
    N Engl J Med; 2003 Oct; 349(17):1647-55. PubMed ID: 14573737
    [No Abstract]   [Full Text] [Related]  

  • 34. Gout and hyperuricemia.
    Chilappa CS; Aronow WS; Shapiro D; Sperber K; Patel U; Ash JY
    Compr Ther; 2010; 36():3-13. PubMed ID: 21229813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A swollen knee.
    Usatine RP; Sacks B; Sorci J
    J Fam Pract; 2003 Jan; 52(1):53-5. PubMed ID: 12540313
    [No Abstract]   [Full Text] [Related]  

  • 36. The management of gout at an academic healthcare center in Beijing: a physician survey.
    Fang W; Zeng X; Li M; Chen LX; Schumacher HR; Zhang F
    J Rheumatol; 2006 Oct; 33(10):2041-9. PubMed ID: 17014019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing gout: there's more we can do.
    Mead T; Arabindoo K; Smith B
    J Fam Pract; 2014 Dec; 63(12):707-13. PubMed ID: 25486309
    [No Abstract]   [Full Text] [Related]  

  • 38. A survey of current evaluation and treatment of gout.
    Schlesinger N; Moore DF; Sun JD; Schumacher HR
    J Rheumatol; 2006 Oct; 33(10):2050-2. PubMed ID: 17014020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study.
    Perez-Ruiz F; Atxotegi J; Hernando I; Calabozo M; Nolla JM
    Arthritis Rheum; 2006 Oct; 55(5):786-90. PubMed ID: 17013833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A survey of current prescribing practices of antiinflammatory and urate-lowering drugs in gouty arthritis.
    Stuart RA; Gow PJ; Bellamy N; Campbell J; Grigor R
    N Z Med J; 1991 Mar; 104(908):115-7. PubMed ID: 2011292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.